Toxoplasma gondii Activators
GRA24 activators encompass a repertoire of chemical compounds that augment the functional activity of GRA24, a pivotal protein in the immune modulation exerted by the parasite Toxoplasma gondii. Compounds such as Forskolin and Resveratrol target cyclic AMP and NF-κB pathways, respectively, facilitating the enhancement of GRA24's role in manipulating host cell signaling in favor of the parasite's survival and replication. Forskolin's upregulation of cAMP levels activates protein kinase A, thereby potentiating GRA24's ability to modulate immune responses, while Resveratrol's effect on NF-κB signaling enhances GRA24's interaction with the p65 subunit, culminating in an augmented anti-inflammatory response.
GRA24 activators are a suite of chemical entities that indirectly enhance the functional activity of Toxoplasma gondii's GRA24, a protein crucial to the parasite's ability to modulate host immune responses. Forskolin, by elevating cAMP, indirectly bolsters GRA24's capacity to engage the cAMP-dependent protein kinase A (PKA) pathway, thereby amplifying the immunomodulatory influence of GRA24 on the host cell. Resveratrol further strengthens this modulation by engaging with NF-κB signaling pathways, promoting GRA24's interaction with the p65 subunit and thus enhancing the anti-inflammatory response beneficial to the parasite. Other compounds such as Bisindolylmaleimide I and Epigallocatechin gallate, which inhibit PKC and various kinases respectively, can potentially lessen competitive phosphorylation events, thereby facilitating GRA24's interaction with host cell signaling components. Together, these activators, though acting indirectly, are united in their common objective to potentiate GRA24's unique and pivotal role in subverting host cellular mechanisms to favor Toxoplasma gondii's intracellular survival and proliferation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Increases intracellular cAMP, which can enhance the GRA24-mediated immune modulation by promoting the cAMP-dependent PKA signaling pathway, known to influence the host cell immune response during Toxoplasma gondii infection. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Acts as an immunomodulator by influencing NF-κB signaling; enhances GRA24 interaction with p65 subunit of NF-κB in host cells, potentially increasing the anti-inflammatory effects typically induced by GRA24. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Specific PKC inhibitor that can lead to an increase in GRA24-mediated modulation of host cell signaling pathways by reducing competitive phosphorylation events that could otherwise diminish the protein's effects. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Induces antioxidant response elements via Nrf2 signaling, possibly enhancing the protective role of GRA24 against oxidative stress in host cells infected by Toxoplasma gondii. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Modulates various signaling pathways including NF-κB, and could enhance the immune-modulatory function of GRA24 by promoting its interaction with host signaling components. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Inhibits multiple kinases, potentially augmenting GRA24's ability to modulate host cell signaling pathways by reducing kinase-mediated competitive signaling. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P receptor modulator that may amplify GRA24's role in host cell immune modulation through S1P-mediated signaling pathways which are implicated in the immune response to Toxoplasma gondii. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PKC activator that could potentiate the immune-modulatory effects of GRA24 by enhancing PKC-mediated signaling pathways within host cells infected by Toxoplasma gondii. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that may indirectly enhance the activity of GRA24 by modulating the MAPK/ERK pathway, possibly favoring GRA24's role in host cell manipulation during Toxoplasma gondii infection. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that could enhance the GRA24-mediated signaling by reducing competitive PI3K/Akt signaling, potentially increasing the immunomodulatory effects of GRA24 in host cells. | ||||||